1. Home
  2. RGEN vs DLB Comparison

RGEN vs DLB Comparison

Compare RGEN & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DLB
  • Stock Information
  • Founded
  • RGEN 1981
  • DLB 1965
  • Country
  • RGEN United States
  • DLB United States
  • Employees
  • RGEN N/A
  • DLB N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DLB Multi-Sector Companies
  • Sector
  • RGEN Health Care
  • DLB Miscellaneous
  • Exchange
  • RGEN Nasdaq
  • DLB Nasdaq
  • Market Cap
  • RGEN 8.0B
  • DLB 7.9B
  • IPO Year
  • RGEN N/A
  • DLB 2005
  • Fundamental
  • Price
  • RGEN $118.15
  • DLB $74.69
  • Analyst Decision
  • RGEN Buy
  • DLB Strong Buy
  • Analyst Count
  • RGEN 12
  • DLB 4
  • Target Price
  • RGEN $172.67
  • DLB $101.75
  • AVG Volume (30 Days)
  • RGEN 819.3K
  • DLB 373.7K
  • Earning Date
  • RGEN 04-29-2025
  • DLB 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • DLB 1.75%
  • EPS Growth
  • RGEN N/A
  • DLB 36.08
  • EPS
  • RGEN N/A
  • DLB 2.64
  • Revenue
  • RGEN $650,429,000.00
  • DLB $1,320,184,000.00
  • Revenue This Year
  • RGEN $13.93
  • DLB $6.38
  • Revenue Next Year
  • RGEN $14.35
  • DLB $4.65
  • P/E Ratio
  • RGEN N/A
  • DLB $28.62
  • Revenue Growth
  • RGEN 4.88
  • DLB 4.03
  • 52 Week Low
  • RGEN $102.97
  • DLB $66.35
  • 52 Week High
  • RGEN $182.52
  • DLB $89.66
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 38.20
  • DLB 43.49
  • Support Level
  • RGEN $120.11
  • DLB $76.69
  • Resistance Level
  • RGEN $129.42
  • DLB $77.59
  • Average True Range (ATR)
  • RGEN 6.02
  • DLB 1.01
  • MACD
  • RGEN -1.20
  • DLB -0.02
  • Stochastic Oscillator
  • RGEN 5.96
  • DLB 29.47

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About DLB Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.

Share on Social Networks: